Genentech, Inc. Says Key Patent Rejected, May Appeal
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc. (NYSE:DNA) announced that it has received notification today from the U.S. Patent and Trademark Office that a final Office action has been issued and mailed rejecting the patentability of claims of the Cabilly patent, et al. U.S. Patent No. 6,331,415 ('415 patent).